These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15497030)
1. Endothelial injury markers with high-dose intravenous iron therapy in renal failure. Borawski J; Gozdzikiewicz J; Abramowicz P; Naumnik B; Mysliwiec M Clin Appl Thromb Hemost; 2004 Oct; 10(4):403-6. PubMed ID: 15497030 [TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis. Garcia-Fernandez N; Echeverria A; Sanchez-Ibarrola A; Páramo JA; Coma-Canella I Nephrology (Carlton); 2010 Mar; 15(2):178-83. PubMed ID: 20470276 [TBL] [Abstract][Full Text] [Related]
3. A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. Stoves J; Inglis H; Newstead CG Nephrol Dial Transplant; 2001 May; 16(5):967-74. PubMed ID: 11328902 [TBL] [Abstract][Full Text] [Related]
4. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Silverberg DS; Iaina A; Peer G; Kaplan E; Levi BA; Frank N; Steinbruch S; Blum M Am J Kidney Dis; 1996 Feb; 27(2):234-8. PubMed ID: 8659499 [TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease. Blaustein DA; Schwenk MH; Chattopadhyay J; Singh H; Daoui R; Gadh R; Avram MM Kidney Int Suppl; 2003 Nov; (87):S72-7. PubMed ID: 14531777 [TBL] [Abstract][Full Text] [Related]
6. Elevated cardiac troponin T in hemodialysis patients receiving more intravenous iron sucrose. Guz G; Sahinarslan A; Dhondt AW; Bagdatoglu O; Kavutcu M; Reis KA; Yalçin R; Bali M; Sindel S Ren Fail; 2004 Nov; 26(6):663-72. PubMed ID: 15600258 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia. Wall GC; Pauly RA Am J Health Syst Pharm; 2008 Jan; 65(2):150-3. PubMed ID: 18192261 [TBL] [Abstract][Full Text] [Related]
8. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. Toblli JE; Lombraña A; Duarte P; Di Gennaro F J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147 [TBL] [Abstract][Full Text] [Related]
9. Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin. Anbu AT; Kemp T; O'donnell K; Smith PA; Bradbury MG Acta Paediatr; 2005 Dec; 94(12):1738-41. PubMed ID: 16431410 [TBL] [Abstract][Full Text] [Related]
10. [Indications and practical management of parenteral iron therapy]. Kosch M; Schaefer RM Wien Klin Wochenschr; 2003 Jun; 115(11):380-4. PubMed ID: 12879735 [TBL] [Abstract][Full Text] [Related]
12. Intravenous iron sucrose: establishing a safe dose. Chandler G; Harchowal J; Macdougall IC Am J Kidney Dis; 2001 Nov; 38(5):988-91. PubMed ID: 11684551 [TBL] [Abstract][Full Text] [Related]
13. Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child. Wood DM; Thomson AH; Lawes M; Jones AL; Dargan PI Ther Drug Monit; 2005 Aug; 27(4):405-8. PubMed ID: 16044093 [TBL] [Abstract][Full Text] [Related]
14. Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition. Michaud L; Guimber D; Mention K; Neuville S; Froger H; Gottrand F; Turck D Clin Nutr; 2002 Oct; 21(5):403-7. PubMed ID: 12381338 [TBL] [Abstract][Full Text] [Related]
15. Intravenous iron sucrose versus oral iron administration for the postoperative treatment of post-bariatric abdominoplasty anaemia: an open-label, randomised, superiority trial in Brazil. Montano-Pedroso JC; Bueno Garcia E; Alcântara Rodrigues de Moraes M; Francescato Veiga D; Masako Ferreira L Lancet Haematol; 2018 Jul; 5(7):e310-e320. PubMed ID: 29958570 [TBL] [Abstract][Full Text] [Related]
16. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Onken JE; Bregman DB; Harrington RA; Morris D; Buerkert J; Hamerski D; Iftikhar H; Mangoo-Karim R; Martin ER; Martinez CO; Newman GE; Qunibi WY; Ross DL; Singh B; Smith MT; Butcher A; Koch TA; Goodnough LT Nephrol Dial Transplant; 2014 Apr; 29(4):833-42. PubMed ID: 23963731 [TBL] [Abstract][Full Text] [Related]
17. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Bayoumeu F; Subiran-Buisset C; Baka NE; Legagneur H; Monnier-Barbarino P; Laxenaire MC Am J Obstet Gynecol; 2002 Mar; 186(3):518-22. PubMed ID: 11904617 [TBL] [Abstract][Full Text] [Related]
18. Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients. Bolaños L; González-Juanatey C; Testa A; Ranero R Adv Perit Dial; 2008; 24():90-5. PubMed ID: 18986009 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study. Deng Y; Wu J; Jia Q Med Sci Monit; 2017 Mar; 23():1254-1260. PubMed ID: 28285317 [TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Van Wyck DB; Roppolo M; Martinez CO; Mazey RM; McMurray S; Kidney Int; 2005 Dec; 68(6):2846-56. PubMed ID: 16316362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]